<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2025-6-56-61</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1879</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Клинико-эндоскопические признаки патологии пищевода у пациентов с системной склеродермией</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and endoscopic signs of esophageal involvement in patients with systemic sclerosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2569-1699</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгушина</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgushina</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>1454141, Челябинск, ул. Воровского, 64</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5954-3112</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хусаинова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khusainova</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гузель Мидхатовна Хусаинова</p><p>1454141, Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>Guzel Midhatovna Khusainova</p><p>64, Vorovskogo Street, Chelyabinsk 454141</p></bio><email xlink:type="simple">husainovagm@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6444-4573</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хихлова</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Khikhlova</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454048, Челябинск, ул. Воровского, 70</p></bio><bio xml:lang="en"><p>70, Vorovskogo Street, Chelyabinsk 454048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3481-8092</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саенко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Saenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>1454141, Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Street, Chelyabinsk 454141</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5599-8248</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Несмеянова</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Nesmeyanova</surname><given-names>O. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454048, Челябинск, ул. Воровского, 70</p></bio><bio xml:lang="en"><p>70, Vorovskogo Street, Chelyabinsk 454048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7385-8505</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олевская</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Olevskaya</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>454048, Челябинск, ул. Воровского, 70</p></bio><bio xml:lang="en"><p>70, Vorovskogo Street, Chelyabinsk 454048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1373-2871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Загитдинова</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Zagitdinova</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>1454141, Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Street, Chelyabinsk 454141</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-5959-5828</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Штыков</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Shty`kov</surname><given-names>S. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>1454141, Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Street, Chelyabinsk 454141</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-8510-7698</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кинзябулатов</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kinzyabulatov</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>1454141, Челябинск, ул. Воровского, 64</p></bio><bio xml:lang="en"><p>64, Vorovskogo Street, Chelyabinsk 454141</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Челябинская областная клиническая больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>12</month><year>2025</year></pub-date><volume>19</volume><issue>6</issue><fpage>56</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Долгушина А.И., Хусаинова Г.М., Хихлова А.О., Саенко А.А., Несмеянова О.Б., Олевская Е.Р., Загитдинова М.Д., Штыков С.К., Кинзябулатов Р.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Долгушина А.И., Хусаинова Г.М., Хихлова А.О., Саенко А.А., Несмеянова О.Б., Олевская Е.Р., Загитдинова М.Д., Штыков С.К., Кинзябулатов Р.В.</copyright-holder><copyright-holder xml:lang="en">Dolgushina A.I., Khusainova G.M., Khikhlova A.O., Saenko A.A., Nesmeyanova O.B., Olevskaya E.R., Zagitdinova M.D., Shty`kov S.K., Kinzyabulatov R.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1879">https://mrj.ima-press.net/mrj/article/view/1879</self-uri><abstract><p>Поражение пищевода – одно из наиболее частых висцеральных проявлений системной склеродермии (ССД), однако его связь с течением заболевания изучена недостаточно. Наиболее доступным инструментальным методом исследования эзофагогастродуоденальной зоны считается эндоскопия, которая в сочетании с клиническими симптомами является основой диагностики заболеваний пищевода.</p><p>Цель исследования – изучить частоту клинико-эндоскопических признаков патологии пищевода и их связь с клиническими проявлениями ССД.</p><sec><title>Материал и методы</title><p>Материал и методы. Обследован 81 пациент с ССД, находившийся на стационарном лечении в ГБУЗ «Челябинская областная клиническая больница» с декабря 2019 г. по сентябрь 2024 г.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. У 40 (49,4%) пациентов имелись характерные для патологии пищевода жалобы на дисфагию (n=38, 46,9%) и изжогу (n=14, 17,3%). При проведении эзофагогастродуоденоскопии у 13 (16%) пациентов выявлен эрозивный эзофагит. В 5 (6,2%) случаях установлен эзофагит степени В и более, в 2 (2,5%) – степени D. У пациентов с эрозивным эзофагитом чаще встречались дигитальные язвочки и рубчики, в лечении использовались силденафил и циклофосфамид – ЦФ (р&lt;0,05). Частота выявления эрозий пищевода была в 4,12 раза выше при наличии дигитальных язв (95% доверительный интервал, ДИ1,20–14,13; р&lt;0,05) и в 9,48 раза выше при применении ЦФ (95% ДИ 1,81–49,45). Частота интерстициального заболевания легких (ИЗЛ) не зависела от наличия эрозивного эзофагита, однако возрастала в 4,33 раза при наличии атонии пищевода по данным рентгеноскопии (95% ДИ 1,24–15,2).</p></sec><sec><title>Заключение</title><p>Заключение. Пациенты с ССД в половине случаев предъявляют жалобы на дисфагию или изжогу. Эрозивный эзофагит ассоциирован с более выраженными нарушениями микроциркуляции и лечением ЦФ. ИЗЛ чаще встречалось при обнаружении рентгенологических признаков атонии пищевода.</p></sec></abstract><trans-abstract xml:lang="en"><p>Esophageal involvement is one of the most frequent visceral manifestations of systemic sclerosis (SSc), however, its association with the course of the disease has been insufficiently studied. Endoscopy is considered the most accessible instrumental method for examining the esophagogastroduodenal zone, and in combination with clinical symptoms forms the basis for diagnosing esophageal diseases.</p><sec><title>Objective</title><p>Objective: to investigate the frequency of clinical and endoscopic signs of esophageal disorders (ED) and their association with clinical manifestations of SSc.</p></sec><sec><title>Material and methods</title><p>Material and methods. A total of 81 patients with SSc hospitalized at the Chelyabinsk Regional Clinical Hospital from December 2019 to September 2024 were examined.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. In 40 (49.4%) patients, symptoms characteristic of ED were present: dysphagia (n=38, 46.9%) and heartburn (n=14, 17.3%). During esophagogastroduodenoscopy, erosive esophagitis (EE) was detected in 13 (16%) patients. In 5 (6.2%) cases, esophagitis grade B or higher was identified, and in 2 (2.5%) – grade D. Patients with EE more frequently had digital ulcers and scars, and treatment included sildenafil and cyclophosphamide (CYP) (p&lt;0.05). The frequency of esophageal erosions was 4.12 times higher in the presence of digital ulcers (95% confidence interval, CI 1.20–14.13; p&lt;0.05) and 9.48 times higher with CYP use (95% CI 1.81–49.45). The frequency of interstitial lung disease (ILD) did not depend on the presence of EE, but increased 4.33 times in the presence of esophageal atony according to radiography (95% CI 1.24–15.2).</p></sec><sec><title>Conclusion</title><p>Conclusion. Patients with SSc report dysphagia or heartburn in half of the cases. EE is associated with more pronounced microcirculatory disturbances and treatment with CYP. ILD occurred more frequently when radiologic signs of esophageal atony were present.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>системная склеродермия</kwd><kwd>поражение пищевода</kwd><kwd>эзофагит</kwd><kwd>пищевод Барретта</kwd><kwd>распространенность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic sclerosis</kwd><kwd>esophageal involvement</kwd><kwd>esophagitis</kwd><kwd>Barrett’s esophagus</kwd><kwd>prevalence</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The investigation has not been sponsored</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мороз ЕВ, Попкова ТВ, Каратеев АЕ. Патология желудочно-кишечного тракта при системных ревматических заболеваниях: краткий описательный обзор. Научно-практическая ревматология. 2022; 60(6):578-586.</mixed-citation><mixed-citation xml:lang="en">Moroz EV, Popkova TV, Karateev AE. Manifestations of the gastrointestinal tract in systemic rheumatic diseases: A narrative review. Nauchno-prakticheskaya revmatologiya. 2022; 60(6):578-586. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nassar M, Ghernautan V, Nso N, et al. Gastrointestinal involvement in systemic sclerosis: An updated review. Medicine (Baltimore). 2022 Nov 11;101(45):e31780. doi: 10.1097/MD.0000000000031780.</mixed-citation><mixed-citation xml:lang="en">Nassar M, Ghernautan V, Nso N, et al. Gastrointestinal involvement in systemic sclerosis: An updated review. Medicine (Baltimore). 2022 Nov 11;101(45):e31780. doi: 10.1097/MD.0000000000031780.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Foocharoen C, Chunlertrith K, Mairiang P, et al. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. Sci Rep. 2020 Jan 21;10(1):769. doi: 10.1038/s41598-020-57636-0.</mixed-citation><mixed-citation xml:lang="en">Foocharoen C, Chunlertrith K, Mairiang P, et al. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. Sci Rep. 2020 Jan 21;10(1):769. doi: 10.1038/s41598-020-57636-0.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Voulgaris TA, Karamanolis GP. Esophageal manifestation in patients with scleroderma. World J Clin Cases. 2021 Jul 16;9(20):54085419. doi: 10.12998/wjcc.v9.i20.5408.</mixed-citation><mixed-citation xml:lang="en">Voulgaris TA, Karamanolis GP. Esophageal manifestation in patients with scleroderma. World J Clin Cases. 2021 Jul 16;9(20):54085419. doi: 10.12998/wjcc.v9.i20.5408.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Salaffi F, Di Carlo M, Carotti M, et al. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study. Radiol Med. 2018 Sep;123(9):655-663. doi: 10.1007/s11547-018-0894-3.</mixed-citation><mixed-citation xml:lang="en">Salaffi F, Di Carlo M, Carotti M, et al. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study. Radiol Med. 2018 Sep;123(9):655-663. doi: 10.1007/s11547-018-0894-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kimmel JN, Carlson DA, Hinchcliff M, et al. The association between systemic sclerosis disease manifestations and esophageal highresolution manometry parameters. Neurogastroenterol Motil. 2016 Aug;28(8):1157-65. doi: 10.1111/nmo.12813.</mixed-citation><mixed-citation xml:lang="en">Kimmel JN, Carlson DA, Hinchcliff M, et al. The association between systemic sclerosis disease manifestations and esophageal highresolution manometry parameters. Neurogastroenterol Motil. 2016 Aug;28(8):1157-65. doi: 10.1111/nmo.12813.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kreuter M, Bonella F, Blank N, et al. Antiacid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. Rheumatology (Oxford). 2023 Sep 1;62(9):3067-3074. doi: 10.1093/rheumatology/kead023.</mixed-citation><mixed-citation xml:lang="en">Kreuter M, Bonella F, Blank N, et al. Antiacid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. Rheumatology (Oxford). 2023 Sep 1;62(9):3067-3074. doi: 10.1093/rheumatology/kead023.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024 Jan 5;73(2): 361-371. doi: 10.1136/gutjnl-2023-330616.</mixed-citation><mixed-citation xml:lang="en">Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024 Jan 5;73(2): 361-371. doi: 10.1136/gutjnl-2023-330616.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med. 2009 Mar 1;179(5):408-13. doi: 10.1164/rccm.200808-1359OC.</mixed-citation><mixed-citation xml:lang="en">Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med. 2009 Mar 1;179(5):408-13. doi: 10.1164/rccm.200808-1359OC.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vettori S, Tolone S, Capocotta D, et al. Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value. Clin Rheumatol. 2018 May;37(5): 1239-1247. doi: 10.1007/s10067-018-4026-1.</mixed-citation><mixed-citation xml:lang="en">Vettori S, Tolone S, Capocotta D, et al. Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value. Clin Rheumatol. 2018 May;37(5): 1239-1247. doi: 10.1007/s10067-018-4026-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Reddy CA, McGowan E, Yadlapati R, Peterson K. AGA Clinical Practice Update on Esophageal Dysfunction Due to Disordered Immunity and Infection: Expert Review. Clin Gastroenterol Hepatol. 2024 Dec;22(12):23782387. doi: 10.1016/j.cgh.2024.08.027.</mixed-citation><mixed-citation xml:lang="en">Reddy CA, McGowan E, Yadlapati R, Peterson K. AGA Clinical Practice Update on Esophageal Dysfunction Due to Disordered Immunity and Infection: Expert Review. Clin Gastroenterol Hepatol. 2024 Dec;22(12):23782387. doi: 10.1016/j.cgh.2024.08.027.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ. Системная склеродермия. В кн.: Насонов ЕЛ, редактор. Российские клинические рекомендации. Ревматология. Москва: ГЭОТАР-Медиа; 2017. С. 142-166.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Systemic scleroderma. In: Nasonov EL, editor. Russian clinical guidelines. Rheumatology. Moscow: GEOTAR-Media; 2017. P. 142-166.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин ВТ, Трухманов АС, Маев ИВ и др. Диагностика и лечение гастроэзофагеальной рефлюксной болезни (Рекомендации Российской гастроэнтерологической ассоциации, Российского научного медицинского общества терапевтов, Российского общества профилактики неинфекционных заболеваний, Научного сообщества по изучению микробиома человека). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2024;34(5):111-135.</mixed-citation><mixed-citation xml:lang="en">Ivashkin VT, Trukhmanov AS, Maev IV, et al. Diagnosis and Treatment of Gastroesophageal Reflux Disease (Clinical Guidelines of the Russian Gastroenterological Association, Russian Scientific Medical Society of Internal Medicine, Russian Society for the Prevention of Noncommunicable Diseases, Scientific Community for Human Microbiome Research). Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2024;34(5):111-135. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Marabotto E, Savarino V, Savarino E. Towards a more precise classification of esophageal motility disorders in patients with systemic sclerosis. Neurogastroenterol Motil. 2022 Jul;34(7):e14416. doi: 10.1111/nmo.14416.</mixed-citation><mixed-citation xml:lang="en">Marabotto E, Savarino V, Savarino E. Towards a more precise classification of esophageal motility disorders in patients with systemic sclerosis. Neurogastroenterol Motil. 2022 Jul;34(7):e14416. doi: 10.1111/nmo.14416.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Alastal Y, Hammad TA, Renno A, et al. Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample. Ann Gastroenterol. 2017;30(5):498-503. doi: 10.20524/aog.2017.0171.</mixed-citation><mixed-citation xml:lang="en">Alastal Y, Hammad TA, Renno A, et al. Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample. Ann Gastroenterol. 2017;30(5):498-503. doi: 10.20524/aog.2017.0171.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Schutyser W, Cruyt L, Vulsteke JB, et al. The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review. Clin Rheumatol. 2020 Jan;39(1):149-157. doi: 10.1007/s10067-019-04794-w.</mixed-citation><mixed-citation xml:lang="en">Schutyser W, Cruyt L, Vulsteke JB, et al. The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review. Clin Rheumatol. 2020 Jan;39(1):149-157. doi: 10.1007/s10067-019-04794-w.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal N, Lopez R, Gabbard S, et al. Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification. Dis Esophagus. 2017 Dec 1;30(12):1-6. doi: 10.1093/dote/dox067.</mixed-citation><mixed-citation xml:lang="en">Aggarwal N, Lopez R, Gabbard S, et al. Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification. Dis Esophagus. 2017 Dec 1;30(12):1-6. doi: 10.1093/dote/dox067.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 2021 Jan;33(1):e14058. doi: 10.1111/nmo.14058.</mixed-citation><mixed-citation xml:lang="en">Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 2021 Jan;33(1):e14058. doi: 10.1111/nmo.14058.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Abozaid HSM, Imam HMK, Abdelaziz MM, et al. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Semin Arthritis Rheum. 2017 Dec;47(3):403-408. doi: 10.1016/j.semarthrit.2017.05.005.</mixed-citation><mixed-citation xml:lang="en">Abozaid HSM, Imam HMK, Abdelaziz MM, et al. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis. Semin Arthritis Rheum. 2017 Dec;47(3):403-408. doi: 10.1016/j.semarthrit.2017.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lahcene M, Oumnia N, Matougui N, et al. Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features. ISRN Rheumatol. 2011;2011:325826. doi:10.5402/2011/325826.</mixed-citation><mixed-citation xml:lang="en">Lahcene M, Oumnia N, Matougui N, et al. Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features. ISRN Rheumatol. 2011;2011:325826. doi:10.5402/2011/325826.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Carlson DA, Crowell MD, Kimmel JN, et al. Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1502-6. doi: 10.1016/j.cgh.2016.03.039.</mixed-citation><mixed-citation xml:lang="en">Carlson DA, Crowell MD, Kimmel JN, et al. Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1502-6. doi: 10.1016/j.cgh.2016.03.039.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kadakuntla A, Juneja A, Sattler S, et al. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol. 2021 Aug 21;27(31):5201-5218. doi: 10.3748/wjg.v27.i31.5201.</mixed-citation><mixed-citation xml:lang="en">Kadakuntla A, Juneja A, Sattler S, et al. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol. 2021 Aug 21;27(31):5201-5218. doi: 10.3748/wjg.v27.i31.5201.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Petcu A, Ghib LJ, Grad SM, et al. Upper gastrointestinal involvement in systemic sclerosis: Findings in a real-life setting. Exp Ther Med. 2019 Dec;18(6):5095-5100. doi: 10.3892/etm.2019.8125.</mixed-citation><mixed-citation xml:lang="en">Petcu A, Ghib LJ, Grad SM, et al. Upper gastrointestinal involvement in systemic sclerosis: Findings in a real-life setting. Exp Ther Med. 2019 Dec;18(6):5095-5100. doi: 10.3892/etm.2019.8125.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев АЕ, Мовсисян ММ, Ананьева ЛП, Раденска-Лоповок СГ. Клинические, эндоскопические и морфологические проявления поражения пищевода при системной склеродермии. Клиническая медицина. 2014;92(6):67-74.</mixed-citation><mixed-citation xml:lang="en">Karateev AE, Movsisyan MM, Anan'eva LP, Radenska-Lopovok SG. Clinical, endoscopic and morphological manifestations of oesophageal lesion in systemic scleroderma. Klinicheskaya meditsina. 2014;92(6):67-74. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hara M, Ueha R, Sato T, et al. Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis. J Clin Med. 2023 May 13;12(10):3448. doi: 10.3390/jcm12103448.</mixed-citation><mixed-citation xml:lang="en">Hara M, Ueha R, Sato T, et al. Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis. J Clin Med. 2023 May 13;12(10):3448. doi: 10.3390/jcm12103448.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tesic-Rajkovic S, Radovanovic-Dinic B. Lesions in the oral cavity and esophagus caused by prescribed drugs: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):21-27. doi: 10.5507/bp.2021.059.</mixed-citation><mixed-citation xml:lang="en">Tesic-Rajkovic S, Radovanovic-Dinic B. Lesions in the oral cavity and esophagus caused by prescribed drugs: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):21-27. doi: 10.5507/bp.2021.059.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">De Lorenzis E, Alonzi G, Natalello G, Berardini L. POS1418 Esophageal mucosal erosions can predict the deterioration of lung function over a four-year follow-up period and long-term mortality in patients with interstitial lung disease associated with scleroderma. Annals of the Rheumatic Diseases. 2024 Jun;83(Suppl 1):1062.2-1063. doi:10.1136/annrheumdis-2024-eular.4990.</mixed-citation><mixed-citation xml:lang="en">De Lorenzis E, Alonzi G, Natalello G, Berardini L. POS1418 Esophageal mucosal erosions can predict the deterioration of lung function over a four-year follow-up period and long-term mortality in patients with interstitial lung disease associated with scleroderma. Annals of the Rheumatic Diseases. 2024 Jun;83(Suppl 1):1062.2-1063. doi:10.1136/annrheumdis-2024-eular.4990.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
